Renin activity and blood pressure in response to chronic episodic hypoxia

Hypertension

Volumn 34, Issue 2, 1999, Pages 309-314

  Fletcher, Eugene C ^a   Bao, Gang ^a   Li, Rena ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Blood pressure; Denervation, renal; Hypertension, systemic; Hypoxia; Renin angiotensin system; Sleep apnea syndromes; Sympathetic nervous system

Indexed keywords

LOSARTAN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CHEMORECEPTOR; CONTROLLED STUDY; DENERVATION; HYPOXIA; INTRAGASTRIC DRUG ADMINISTRATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENAL ARTERY; SLEEP APNEA SYNDROME;

EID: 0032870245     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.34.2.309     Document Type: Article

References (38)

1. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep. 1987;10:35-44.
2. Hedner J, Ejnell H, Sellgren J, Hedner R, Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens. 1988;6:S529-S531.
3. Morgan BJ, Crabtree DC, Palta M, Skatrud J. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol. 1995;79:205-213.
4. Fletcher EC, Lesske J, Qian W, Miller CC, Unger T. Repetitive, episodic hypoxia causes diumal elevation of systemic blood pressure in rats. Hypertension. 1992:19:555-561.
5. Fletcher EC. Lesske J, Behm R, Miller CC, Unger T. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol. 1992;72:1978-1984.
6. Fletcher EC, Lesske J, Culman J, Miller III CC, Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension. 1992;20:612-619.
7. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol. 1997;83:95-101.
8. DiBona, GF. Sympathetic nervous system influences on the kidney: role in hypertension. Am J Hypertens. 1989;2:119S-124S.
9. Loeffler JR, Stockigt JR, Ganong WF. Effect of alpha and beta adrenergic blocking agents on the increase in renin secretion produced by stimulation of renal nerves. Neuroendocrinology 1972;10:129-138.
10. Okamoto K, Aoki K. Development of a strain of spontaneously hypertensive rats. Jpn Circ J. 1967;27:282-293.
11. Spector S, Fleisch JH, Maling HM, Brodie BB. Vascular smooth muscle reactivity in normotensive and hypertensive rats. Science. 1969;166: 1300-1301.
12. Norman RA Jr, Dzielak DJ. Role of renal nerves in onset and maintenance of spontaneous hypertension. Am J Physiol. 1982;243: H284-H288.
13. Fink GD, Bryan WJ, Mann M, Osborn J, Werber A. Continuous blood pressure measurement in rats with aortic baroreceptor deafferentation. Am J Physiol. 1981;241:H268-H272.
14. Goldstein DS, Feuerstein G, Izzo JL Jr. Liquid chromatography for measuring norepinephrine and epinephrine in man. Life Sci. 1981;28: 467-475.
15. Mitchell JR, Taylor AA, Pool JL, Lake CR, Rollins ED, Barter FF. Renin-aldosterone profiling in hypertension. Ann Intern Med. 1977;87: 596-612.
16. Schmedtje JF Jr, Liu WL, Taylor AA. Cardiovascular deconditioning through head-down tilt bed rest increases blood pressure variability and plasma renin activity. Aviat Space Environ Med. 1996;67:539-546.
17. Kline RL, Mercer PF. Functional reinnervation and development of supersensitivity to NE after renal denervation in rats. Am J Physiol. 1980;238:R353-R358.
18. Goldstein DS. Plasma catecholamines and essential hypertension: an analytical review. Hypertension. 1983;5:86-99.
19. Oparil S. The sympathetic nervous system in clinical and experimental hypertension. Kidney Int. 1986;30:5437-5452.
20. Egan B, Panis R, Hinderliter A, Schork N, Julius S. Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest. 1987;80:812-817.
21. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans: evidence from direct intraneural recordings. Hypertension 1989;14:177-183.
22. Miyajima E, Yamada Y, Yoshida Y, Matsukawa T, Shionoiri H, Tochikubo O, Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension. 1991;17: 1057-1062.
23. Gudbjornsdottir S, Lonnroth P, Bergmann-Sverrisdottir Y, Wallin BG, Elam M. Sympathetic nerve activity and insulin in obese normotensive and hypertensive men. Hypertension. 1996;27:276-280.
24. Fukuda Y, Sato A, Trzebski A. Carotid chemoreceptor discharge responses to hypoxia and hypercapnia in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst. 1987;19:1-11.
25. Somers VK, Mark AL, Zavala DC, Abboud FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol. 1989;67:2095-2100.
26. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest. 1993;103:1763-1768.
27. Katholi RE, Whitlow PL, Hageman GR, Woods WT. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens. 1984;2:349-359.
28. Recordati G, Moss NG, Genovesi S, Rogenes P. Renal chemoreceptors. J Auton Nerv Syst. 1981;3:227-251.
29. Regolli D, Park WK, Rioux F. Pharmacology of hypertension. Pharmacol Rev. 1974;26:69-123.
30. Floras JS, Aylward PE, Victor RG, Mark AL, Abboud FM. Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest. 1988;81: 1265-1274.
31. Floras JS, Aylward PE, Mark AL, Abboud FM. Adrenalin facilitates neurogenic vasoconstriction in borderline hypertensive subjects. J Hypertens. 1990;8:443-448.
32. Bevan RD. Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension. 1984;6(suppl III):III-19-III-26.
33. Hart MN, Heistad DD, Brody MJ. Effect of chronic hypertension and sympathetic denervation on wall/lumen ratio of cerebral vessels. Hypertension. 1980;2:419-423.
34. Simpson PC, Kariya K, Darns LR, Long CS, Karliner JS. Adrenergic hormones and control of cardiac myocyte growth. Mol Cell Biochem. 1991;104:35-43.
35. Korner PI, Bobik A, Angus JA, Adams MA, Friberg P. Resistance control in hypertension. J Hypertens. 1989;7:S125-S134.
36. Narkiewicz K, Montano N, Cogliati C, van de Borne PJH, Dyken ME, Sommers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation. 1998;98:1071-1077.
37. Carlson JT, Rangemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnea. J Hypertens. 1996;14:577-584.
38. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME, Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens. 1999;17:61-66.